FDA Inspection 1215835 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on August 15, 2023 in Lansing, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 15, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Lansing, IL (United States)